XML 12 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 41,617,891 $ 28,094,936
Prepaid assets and other current assets 595,016 1,092,462
Total current assets 42,212,907 29,187,398
Property and equipment, net 945,365
Total assets 43,158,272 29,187,398
Current liabilities:    
Accounts payable 1,573,384 410,638
Total current liabilities 1,573,384 410,638
Accrued research and development expense (see Note 5) 1,132,013
Total liabilities 1,573,384 1,542,651
Commitments and contingencies (see Note 4)
Stockholders' equity:    
Common stock; $0.001 par value, 45,000,000 shares authorized; 22,226,284 and 18,450,992 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively 22,226 18,451
Additional paid-in capital 70,014,551 43,338,710
Accumulated other comprehensive loss (67,663)
Accumulated deficit (28,384,226) (15,712,414)
Total stockholders' equity 41,584,888 27,644,747
Total liabilities and stockholders' equity $ 43,158,272 $ 29,187,398